antipyrine has been researched along with triphenyltetrazolium in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, JP; Kassell, NF; Kwan, AL; Lee, KS; Solenski, NJ; Yanamoto, H | 1 |
Alkayed, NJ; Harukuni, I; Hurn, PD; Kimes, AS; London, ED; Traystman, RJ | 1 |
Bähr, M; Hermann, DM; Kilic, E | 1 |
Ge, QF; Peng, GP; Wei, EQ; Yu, LF | 1 |
Abe, K; Hayashi, T; Horiuchi, S; Kato, S; Nagano, I; Omori, N; Sato, K; Zhang, W | 1 |
Hara, H; Iwama, T; Nonaka, Y; Shimazawa, M; Yoshimura, S | 1 |
6 other study(ies) available for antipyrine and triphenyltetrazolium
Article | Year |
---|---|
Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia.
Topics: Animals; Antipyrine; Brain; Brain Ischemia; Coloring Agents; Hydroxylation; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Reperfusion; Salicylates; Salicylic Acid; Tetrazolium Salts; Tissue Distribution | 1997 |
Gender-linked brain injury in experimental stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Autoradiography; Brain; Carbon Radioisotopes; Case-Control Studies; Cerebral Arterial Diseases; Cerebral Cortex; Cerebrovascular Circulation; Cohort Studies; Coloring Agents; Estradiol; Estrogens; Female; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Monitoring, Physiologic; Neuroprotective Agents; Ovariectomy; Putamen; Radiopharmaceuticals; Rats; Rats, Inbred SHR; Rats, Wistar; Reperfusion; Risk Factors; Sex Characteristics; Tetrazolium Salts | 1998 |
Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations.
Topics: Animals; Antipyrine; Autoradiography; Brain Edema; Brain Ischemia; Cerebrovascular Circulation; Coloring Agents; Dose-Response Relationship, Drug; Hemodynamics; Heparin; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Recombinant Proteins; Tetrazolium Salts; Tissue Plasminogen Activator | 2001 |
[An improved quantitative method for evaluation of ischemic injury and neuroprotection in mouse brain slices].
Topics: Alprostadil; Animals; Antipyrine; Brain Ischemia; Edaravone; Formazans; Male; Mice; Mice, Inbred ICR; Neuroprotective Agents; Staining and Labeling; Tetrazolium Salts | 2003 |
Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
Topics: Aldehydes; Animals; Antipyrine; Brain Ischemia; Cell Count; Deoxyadenosines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycation End Products, Advanced; Hemorrhage; Immunohistochemistry; In Situ Nick-End Labeling; Male; Rats; Rats, Wistar; Survival Analysis; Tetrazolium Salts; Time Factors; Tissue Plasminogen Activator | 2004 |
Combination effects of normobaric hyperoxia and edaravone on focal cerebral ischemia-induced neuronal damage in mice.
Topics: Animals; Antipyrine; Blood Pressure; Cell Death; Cerebral Infarction; Disease Models, Animal; Edaravone; Free Radical Scavengers; Hyperbaric Oxygenation; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Mice; Neurologic Examination; Neurons; Tetrazolium Salts | 2008 |